⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL338715 | 0.89 | — | — | |
| SCHEMBL562096 | 0.89 | — | — | |
| SCHEMBL27620118 | 0.89 | — | — | |
| SCHEMBL15856059 | 0.80 | — | — | |
| SCHEMBL5586427 | 0.80 | — | — | |
| SCHEMBL515445 | 0.80 | — | — | |
| SCHEMBL1963946 | 0.80 | — | — | |
| SCHEMBL4376282 | 0.80 | — | — | |
| SCHEMBL21836733 | 0.80 | — | — | |
| SCHEMBL15856010 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12440587-B2 | Particles functionalized with imageable radioisotopes and methods of making and use thereof | Boston Scientific Medical Device Limited (IE) | 2025-10-14 | — | — | US | claimed |
| US-11904029-B2 | Particles functionalized with imageable radioisotopes and methods of making and use thereof | Boston Scientific Medical Device Limited (IE) | 2024-02-20 | — | — | US | claimed |
| US-20240050602-A1 | PARTICLES FUNCTIONALIZED WITH THERAPEUTIC RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | UNIV VIRGINIA PATENT FOUNDATION (US) | 2024-02-15 | — | — | US | claimed |
| WO-2022170206-A1 | PARTICLES FUNCTIONALIZED WITH THERAPEUTIC RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-08-11 | — | — | WO | claimed |
| US-12440587-B2 | Particles functionalized with imageable radioisotopes and methods of making and use thereof | Boston Scientific Medical Device Limited (IE) | 2025-10-14 | — | — | US | disclosed |
| US-20240139354-A1 | PARTICLES FUNCTIONALIZED WITH IMAGEABLE RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | Boston Scientific Medical Device Limited (IE) | 2024-05-02 | — | — | US | disclosed |
| US-11904029-B2 | Particles functionalized with imageable radioisotopes and methods of making and use thereof | Boston Scientific Medical Device Limited (IE) | 2024-02-20 | — | — | US | disclosed |
| US-20240050602-A1 | PARTICLES FUNCTIONALIZED WITH THERAPEUTIC RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | UNIV VIRGINIA PATENT FOUNDATION (US) | 2024-02-15 | — | — | US | disclosed |
| CN-116133695-A | Particles functionalized with imageable radioisotope, methods of making and uses thereof | 弗吉尼亚大学专利基金会 | 2023-05-16 | — | — | CN | disclosed |
| EP-4100069-A1 | PARTICLES FUNCTIONALIZED WITH IMAGEABLE RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | University Of Virginia Patent Foundation (US) | 2022-12-14 | — | — | EP | disclosed |
| WO-2022170206-A1 | PARTICLES FUNCTIONALIZED WITH THERAPEUTIC RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-08-11 | — | — | WO | disclosed |
| WO-2021158611-A1 | PARTICLES FUNCTIONALIZED WITH IMAGEABLE RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2021-08-12 | — | — | WO | disclosed |
| US-20210236669-A1 | PARTICLES FUNCTIONALIZED WITH IMAGEABLE RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2021-08-05 | — | — | US | disclosed |
| CN-106495463-B | Method for preparing composite optical fiber with optical crystal or ceramic as core material and quartz as cladding | 中国科学院上海光学精密机械研究所 | 2019-12-20 | — | — | CN | disclosed |
| CN-106495463-A | The composite fiber preparation method that covering made by core material quartz made by optical crystal and pottery | 中国科学院上海光学精密机械研究所 | 2017-03-15 | — | — | CN | disclosed |